| Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF, Benchmarking the Solactive US Biohealthcare Index
November 11, 2025-Solactive is pleased to announce its collaboration with Samsung Active Asset Management on the launch of the KoAct US Biohealthcare Active ETF,which uses the Solactive US Biohealthcare Index as a benchmark. The product aims to provide investors with targeted exposure to US-listed biotechnology and biopharmaceutical companies,reflecting the momentum of groundbreaking healthcare innovation. |
| The US biohealthcare sector is undergoing a rapid transformation,reaffirming its role as the world's leading hub for biotechnology innovation. Advances in precision medicine,gene editing,and mRNA platforms are transitioning from research to commercialization,while artificial intelligence is accelerating drug discovery and development. Supported by regulatory initiatives from the US Food and Drug Administration (FDA),these innovations are shortening approval timelines and strengthening the country’s leadership in medical advancement. |
| ASB Capital and Xtrackers by DWS launch XASB Sukuk ETF on LSE November 5, 2025-Listed on the London Stock Exchange (LSE), the newly launched ETF will democratize access to Sukuk for global investors |